Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $614.2500 (0.38%) ($614.2500 - $614.2500) on Mon. Aug. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.28% (three month average) | RSI | 63 | Latest Price | $614.2500(0.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.3% a day on average for past five trading days. | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) XLV(42%) DIA(37%) IWD(36%) SPLV(36%) | Factors Impacting REGN price | REGN will decline at least -0.64% in a week (0% probabilities). VIXM(-21%) UUP(-6%) TBT(-6%) VXX(-5%) USO(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.64% (StdDev 1.28%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $598.81(2.58%) | 10 Day Moving Average | $590.16(4.08%) | 20 Day Moving Average | $586.98(4.65%) | To recent high | 0% | To recent low | 24% | Market Cap | $65.128b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |